CR CORREGENE Trademark

Trademark Overview


On Wednesday, February 23, 2022, a trademark application was filed for CR CORREGENE with the United States Patent and Trademark Office. The USPTO has given the CR CORREGENE trademark a serial number of 79339666. The federal status of this trademark filing is REGISTERED as of Tuesday, April 25, 2023. This trademark is owned by Corregene Biotechnology Co., Ltd. The CR CORREGENE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Enzyme preparations for medical purposes; surgical implants comprised of living tissues; Biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; biological tissue cultures for medical purposes; diagnostic preparations for medical purposes; stem cells for medical purposes

Cosmetic research; chemical research; chemical analysis; medical laboratory services; medical research; biological research; bacteriological research; Medical and scientific research, namely, conducting clinical trials for others
cr corregene

General Information


Serial Number79339666
Word MarkCR CORREGENE
Filing DateWednesday, February 23, 2022
Status700 - REGISTERED
Status DateTuesday, April 25, 2023
Registration Number7033281
Registration DateTuesday, April 25, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "CORREGENE". Directly above "CORREGENE" are non-latin characters appearing above the wording, that transliterate to "KE RUI SHENG WU", which translate to "OK", "PROPITIOUS" and "BIOLOGY". To the left of the wording and the non-latin characters is an abstract design consisting of circular and curved line shapes depicting the letters "CR".
Goods and ServicesEnzyme preparations for medical purposes; surgical implants comprised of living tissues; Biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; biological tissue cultures for medical purposes; diagnostic preparations for medical purposes; stem cells for medical purposes
Pseudo MarkCR CORREGENE
Transliteration StatementThe non-Latin characters in the mark transliterate to KE", "RUI", "SHENG WU" respectively and this means "ok", "propitious" and "biology" respectively. However, the combined wording "KE RUI SHENG WU" is not a recognizable phrase and has no meaning in English.
Translation of Words in MarkThe English translation of KE" and "RUI" and "SHENG WU" in the mark is "ok", "propitious" and "biology" respectively. The wording "KE RUI SHENG WU" is not a recognizable phrase and in combination has no meaning in a foreign language.
Disclaimer with Predetermined TextTHE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "SHENG WU"
Goods and ServicesCosmetic research; chemical research; chemical analysis; medical laboratory services; medical research; biological research; bacteriological research; Medical and scientific research, namely, conducting clinical trials for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCorregene Biotechnology Co., Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameCorregene Biotechnology Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameCorregene Biotechnology Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Friday, August 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 4, 2023FINAL DISPOSITION PROCESSED
Tuesday, July 25, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 25, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, February 7, 2023NOTIFICATION PROCESSED BY IB
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 18, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 5, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, January 5, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 5, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, January 5, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, December 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 15, 2022REFUSAL PROCESSED BY IB
Monday, October 24, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 24, 2022REFUSAL PROCESSED BY MPU
Wednesday, August 31, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 30, 2022NON-FINAL ACTION WRITTEN
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Tuesday, May 10, 2022APPLICATION FILING RECEIPT MAILED
Friday, May 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 5, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB